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Abstract
Background: Recurrent pyogenic cholangitis (RPC) is common in Asia. Its management differs from
centre to centre.
Methods: A retrospective review of 80 patients undergoing surgery for RPC was performed. Immediate
and longterm outcomes were analysed.
Results: All patients underwent hepaticocutaneousjejunostomy (HCJ) for biliary drainage and stone
removal. Additional hepatectomy was performed in 38 patients with intrahepatic ductal stricture or liver
segmental atrophy. Twenty-three patients had residual stones and 25 had recurrent stones. All patients
with residual stones underwent repeated choledochoscopy (median: four sessions) for stone removal and
obtained confirmation of ductal clearance. Four patients developed cholangiocarcinoma, of which two
died. The complication rate was 17.5%. Most of the complications were wound infections. No mortality
related to surgery occurred. Multivariate analysis found that gender, disease extent (unilobar versus
bilobar) and surgery type (HCJ alone versus HCJ with hepatectomy) were not associated with increased
risk for residual or recurrent stones. A raised preoperative bilirubin level was the only risk factor identified
as associated with an increased risk for recurrent stones (P < 0.001); it was not associated with an
increased risk for residual stones.
Conclusions: Recurrent pyogenic cholangitis is a distinct disease, the management of which requires a
high level of surgical expertise. Hepaticojejunostomy is recommended as the primary drainage procedure,
but hepatectomy should be reserved for complicated RPC.
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Introduction
Recurrent pyogenic cholangitis (RPC) is a disease characterized by
the formation of intrabiliary pigmented stones, which results in
the stricturing of the biliary tree followed by biliary obstruction
and recurrent bouts of cholangitis. It is a peculiar disease entity
usually found in Southeast Asia and was first described by Digby
in 1930.1
In the 1950s, Queen Mary Hospital in Hong Kong received up to
50 new patients with RPC every year (Unpublished data from
Queen Mary Hospital, Department of Surgery database, 1960).
Improvements in the socioeconomic environment resulted in a
fall in incidence over subsequent years to an average of 16.5 new
patients per year in the 1990s.2 Patients classically present with
repeated episodes of cholangitis. The recurrence of cholangitis after
cholecystectomy also raises suspicions of this diagnosis. Typical
imaging features on computed tomography (CT) or cholangio-
graphy [e.g. endoscopic retrograde cholangiopancreatography
(ERCP)] are arrowhead signs, indicating the presence of
intrahepatic ductal stones or strictures (Fig. 1). Both CT and ERCP
are important tools in the management of patients with RPC. They
allow the sites of strictures and intrahepatic stones to be located and
also provide a road map for future surgery.3,4
The management of RPC includes the control of sepsis during
an episode of cholangitis, a delayed definitive procedure in the
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form of hepatectomy or hepaticocutaneousjejunostomy (HCJ),
and subsequent surveillance for malignancy. Hepaticocutaneous-
jejunostomy (Fig. 2) is the mainstay of treatment of RPC. It offers
a platform from which to explore the intrahepatic ducts with
choledochoscopy. The cutaneous stoma (Fig. 3) created can be
closed once ductal clearance is confirmed. In a case of recurrent
cholangitis, the cutaneous limb of the HCJ can be reopened
readily for further choledochoscopy.
The management strategy depends largely on the location of
the stone or stricture. For example, if the main culprit of the
disease is in the left lateral segment of the liver, especially when
parenchymal atrophy or ductal stricture is also present, segmental
liver resection should be the treatment of choice. Hepatectomy
has been shown to achieve a high rate of immediate stone clear-
ance and to result in a low rate of recurrent stone formation.5,6
Surgical techniques for HCJ for RPC have been modified
over the last decade. No longer is a cutaneous stoma routinely
created; instead, a latex drainage T-tube is inserted through the
Roux loop of the jejunal limb to splint the biliary system at the
hepaticojejunostomy, which is usually fashioned with a single
layer of 5–0 polydioxanone suture (either interrupted or continu-
ous) (Fig. 4). This procedure (referred to as ‘modified HCJ’
herein) avoids the need to create a stoma, but offers a similar and
readily available access route to the biliary system.
A few weeks after the procedure, T-tube cholangiography is
performed. The T-tube can be removed when ductal clearance is
confirmed. The tract will close spontaneously within a few days.
The Roux loop of the jejunal limb can be reopened at any time for
further stone removal by choledochoscopy if required.
The management of RPC is made difficult by the presence of
multiple deeply seated intrahepatic ductal stones and strictures.
The rarity of the disease also limits experience in developing a
management strategy. This study looked into recent experiences in
the surgical management of RPC at a tertiary referral centre
in Hong Kong. Immediate outcomes, such as the rate of stone
clearance, and longterm outcomes, such as rates of recurrent stone
formation, recurrent cholangitis and development of cholangio-
carcinoma, were analysed.
Materials and methods
A retrospective review was performed of data for the 80 patients
with RPC who underwent surgical treatment between January
Figure 1 Classical computed tomography images showing dilated intrahepatic ducts with intrahepatic ductal stones and arrowhead signs
involving the left lobe of the liver
Figure 2 Diagram showing hepaticocutaneousjejunostomy
Figure 3 Clinical photograph showing the stoma in
hepaticocutaneousjejunostomy
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2001 and December 2010 at the Department of Surgery, Tung
Wah Hospital, University of Hong Kong. Of these 80 patients, 35
were male and 45 were female. The median follow-up time was 5.3
years and the median patient age was 60 years (range: 29–80
years). Data investigated included details of the types of opera-
tion, rates of residual and recurrent stones, number of episodes of
cholangitis after primary surgery and complication rates after
surgery, as well as the number of patients in the cohort who
developed cholangiocarcinoma.
Diagnoses of RPC were based on clinical and radiological find-
ings of intrahepatic ductal stones or strictures. A residual stone
was defined as incomplete stone clearance revealed during surgery
or by imaging at <3 months after surgery.3 A recurrent stone was
defined as a stone identified >3 months after surgery. Complica-
tions were graded according to the Clavien system of classification
and postoperative mortality was defined as death within 30 days
after the operation. Independent risk factors for the formation of
residual and recurrent stones were identified using chi-squared
tests. Statistically significant risk factors were further analysed by
multivariate analysis. A P-value of <0.05 was considered to indi-
cate statistical significance.
Results
All of the 80 patients underwent HCJ (or modified HCJ) for
biliary drainage and stone removal. Thirty-eight patients (47.5%)
also submitted to hepatectomy; these were the only patients to
have pathological confirmation of the disease, which was acquired
after hepatectomy. Table 1 shows the types of hepatectomy per-
formed. Twenty-three (28.8%) patients had residual stones that
required re-intervention, and 25 (31.3%) patients had recurrent
stones after the primary operation. All of the latter group required
biliary clearance with choledochoscopy via T-tube.
The chi-squared test identified four statistically significant risk
factors for recurrent or residual biliary stones: gender (P = 0.047);
type of surgery (HCJ alone versus HCJ with hepatectomy) (P =
0.039); extent of disease (unilobar versus bilobar) (P = 0.042), and
preoperative serum bilirubin level [normal versus raised (defined
as >20 μmol/l)] (P < 0.001).
Multivariate analysis found that none of gender [odds ratio
(OR) = 0.72; P = 0.622], type of surgery (OR = 0.58; P = 0.332) and
extent of disease (OR = 0.69; P = 0.611) were associated with an
increased risk for the formation of residual or recurrent stones. A
raised preoperative serum bilirubin level was also not associated
with increased risk for residual stones (P = 0.294), but was found
to be an independent risk factor for the formation of recurrent
stones (OR = 13.8; P < 0.001).
Sixteen patients developed recurrent cholangitis after primary
surgery; six of them had a single recurrent attack. The median
number of episodes of cholangitis was 0.5 (range: 0–10 episodes).
All patients with cholangitis required antibiotics and biliary
drainage with choledochoscopy via HCJ. The median number of
choledochoscopy sessions required for biliary clearance was four
(range: 1–51 sessions).
Fourteen (17.5%) patients developed complications, mainly
wound infections, as a result of the surgical management of RPC.
Table 2 shows the different types of complication that occurred.
There was no postoperative mortality.
Four (5.0%) patients developed cholangiocarcinoma and two
of these died of the malignancy during a median follow-up of 36
Figure 4 Diagram illustrating the modified technique for hepati-
cocutaneousjejunostomy with splintage using a T-tube
Table 1 Types of hepatectomy performed
Type of operation n
Left lateral sectionectomy 19
Left hepatectomy 11
Right hepatectomy 5
Right posterior hepatectomy 2
Segment VIII resection 1
Total 38
Table 2 Complications occurring after surgery for recurrent pyo-
genic cholangitis
Complication
grade
Complications,
n
Details
I 10 Wound infection, n = 9
Postoperative ileus, n = 1
II 0
IIIa 1 Intra-abdominal collection, n = 1
(requiring percutaneous drainage)
IIIb 3 Bile leak, n = 1
(requiring open repair)
Incisional hernia, n = 2
(requiring elective hernia repair)
IVa 0
IVb 0
V 0
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months (range: 17–54 months). Overall survival in the cohort was
97.5% after a median follow-up of 63.3 months (range: 20–121
months).
Discussion
Recurrent pyogenic cholangitis is an oriental disease; it is rarely
seen in the West. In 1930, Digby documented its occurrence in
Hong Kong and described eight cases he had encountered.1 The
Queen Mary Hospital, Department of Surgery at the University of
Hong Kong managed up to 50 new patients per year in the 1950s.
The incidence of the disease gradually declined to an average of
16.5 new patients per year in the 1990s as a result of general
improvements in the socioeconomic environment, in which better
social and environmental hygiene reduced the incidence of liver
fluke (Clonorchis sinensis) infestation and thus RPC. However, a
growing incidence of RPC has been observed in theWest as a result
of increased immigration. In Japan, 4.1% of patients who undergo
surgery for biliary stones are eventually diagnosed with RPC.7
Patients with RPC have been considered as ‘stone-forming’.
These patients develop biliary stones even after cholecystectomy.
One study comparing hepatectomy with percutaneous biliary
drainagewith choledochoscopy forRPC found that both treatment
modalities achieved satisfactory stone clearance, but the rate of
stone recurrence in the percutaneous drainage group was much
higher (31.5% versus 5.6%).8 In 1962, Ong pioneered the use of
HCJ at the University of Hong Kong for biliary drainage and stone
removal.9 This technique has long been adopted as the primary
surgical treatment for RPC. Patients with RPCmay require several
sessions of choledochoscopy in order to ensure all biliary stones are
removed.When ductal clearance is confirmed by choledochoscopy
or plain CT, the stoma created can be closed.WithmodifiedHCJ, a
cutaneous stoma is no longer routinely created, but, instead, a
T-tube is inserted to splint the hepaticojejunostomy and is brought
out to the abdominal wall through the Roux loop of the jejunum.
Choledochoscopy is performed via the T-tube, which can be
removed once ductal clearance is confirmed. If recurrent biliary
stone formation occurs, the jejunal limb is reopened for operation.
Observations throughout the past few decades indicate that most
patients are free of residual or recurrent stones after HCJ. In an
instance of recurrence, the stoma can be reopened readily to facili-
tate the removal of further stones.
In the current study, the only identifiable risk factor for
recurrent stone formation was a deranged preoperative serum
bilirubin level. Patients with a raised serum bilirubin level on
presentation have a higher risk for stone recurrence. Whether a
more radical approach using surgical treatments such as hepate-
ctomy will translate into a significant clinical benefit requires
further evaluation.
In the present study, some patients underwent HCJ only and
others underwent both HCJ and hepatectomy. When these two
groups of patients were compared, no statistically significant dif-
ference in the rate of residual or recurrent stone formation
emerged. This probably reflects the effect of a strict patient selec-
tion protocol on surgical outcome. Chronic or recurrent
cholangitis renders the liver atrophic and the affected segment of
liver is usually non-functional. Many authorities therefore advo-
cate hepatectomy in the treatment of RPC. In fact, the study
hospital also performs hepatectomy, but in a more selective
manner. Undoubtedly, the present study includes an element of
selection bias because patients with complicated RPC were treated
with both HCJ and hepatectomy, whereas those with uncompli-
cated disease underwent HCJ only. However, the results have
demonstrated the importance of careful patient selection for
operation; hepatectomy should be reserved for patients with liver
atrophy, segmental intrahepatic biliary stricture or malignancy.
In the current study, 17.5% (n = 14/80) of patients developed
surgical complications, most of which were wound infections.
Biliary stasis, biliary obstruction and in situ biliary catheterization
were all contributing factors. Bile spillage is often unavoidable in
biliary surgery, whether the surgery involves a drainage procedure
or hepatectomy. Therefore, the present authors routinely admin-
ister i.v. antibiotics. Additional doses of antibiotics are given in
prolonged operations.
Four (5.0%) patients in the study cohort developed
cholangiocarcinoma and two of them died of it. Surveillance for
malignancy using tumour markers such as carbohydrate antigen
19-9 (CA 19-9) and carcinoembryonic antigen (CEA), as well as
annual imaging using CT, is therefore essential.
Although the rates of residual and recurrent stones were higher
in the current study than in an earlier study conducted in 2004,6
the complication rate was lower. This probably reflects the impact
of an improved surgical technique, meticulous control of con-
tamination of the surgical field, and the use of antibiotics. None of
the 80 patients died after surgery (i.e. of surgery-related causes),
which probably also reflects the use of a refined surgical technique
for hepatectomy, improved postoperative care and the nutritional
support of patients.
In conclusion, HCJ with or without hepatectomy provides rea-
sonably good results in the treatment of RPC. It is safe and feasible
and offers additional benefits in terms of facilitating salvage
surgery (the reopening of a stoma and repeat choledochoscopy)
for the treatment of recurring stones.
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